RISK ASSESSMENT AND MINIMIZATION FOR PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) (RAMP): A PROGRAM TO ASSESS FOR POTENTIAL EARLY SIGNS AND SYMPTOMS OF PML DURING CLINICAL DEVELOPMENT OF VEDOLIZUMAB

Asit Parikh  1     Megan McAuliffe  2     Kristin Stephens  2     Eugene Major  3     Irving Fox  2     Catherine Milch  2     Serap Sankoh  2     James Provenzale  4     Michael Lev  5     Eric Freedland     Joseph Berger     David Clifford    
1 Takeda Pharmaceuticals International, Inc
2 Millennium Pharmaceuticals, Inc
3 National Institute of Neurological Disorders and Stroke, National Institutes of Health
4 Duke University Medical Center
5 Massa

Session
IBD I

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A216


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing